CSIMarket
 
Cibus Inc   (NASDAQ: CBUS)
 
Price: $1.5900 $0.01 0.633%
Day's High: $1.6399999856948853 Week Perf: -1.85 %
Day's Low: $ 1.57 30 Day Perf: -14.97 %
Volume (M): 73,947 52 Wk High: $ 4.19
Volume (M$): $ 0 52 Wk Avg: $1.78
Open: $1.58 52 Wk Low: $1.09



 Market Capitalization (Millions $) 122
 Shares Outstanding (Millions) 77
 Employees 118
 Revenues (TTM) (Millions $) 4
 Net Income (TTM) (Millions $) -100
 Cash Flow (TTM) (Millions $) -6
 Capital Exp. (TTM) (Millions $) 0

Business Description


Cibus Inc. is an agricultural biotechnology company based in San Diego, California. They focus on developing precision gene editing technologies for the enhancement of crop productivity and quality. Their proprietary technology, known as Rapid Trait Development System (RTDS), allows for precise and efficient modification of plant genes without the incorporation of foreign DNA. This technology has the potential to revolutionize the way crops are engineered for improved traits, making them resistant to pests, diseases, and environmental stresses.

Cibus Inc. aims to address the global challenges of food security and sustainability by providing farmers with innovative and safe solutions to enhance crop yield and quality. Their gene editing platform enables the development of crops with desired traits, allowing for better resource utilization and reduced environmental impact. Cibus has successfully commercialized its first product, SU Canola™, a non-GMO herbicide-tolerant canola variety, and continues to work on developing new traits and crops using their RTDS technology.


   Company Address: 6455 Nancy Ridge Drive San Diego 92121 CA
   Company Phone Number: 450-0008   Stock Exchange / Ticker: NASDAQ CBUS


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
CTVA        4.72% 
RKDA   -10.83%    
• View Complete Report
   



Contract

Cibus Partners with Latin American Consortium to Enhance Rice Herbicide Tolerance Amidst Market Challenges

Published Thu, Aug 28 2025 11:11 AM UTC

In a strategic move to bolster agricultural productivity in Latin America, Cibus Inc. has entered into an agreement with the Centro Internacional de Agricultura Tropical (CIAT) to integrate its proprietary herbicide tolerance trait into elite rice germplasm. This partnership aims to address the region s pressing challenges related to food security and sustainable farming pra...

Partnership

Unlocking Genetic Potential How Cibus and the John Innes Centre Aim to Redefine Fertilizer Use in Agriculture

Published Thu, Jun 12 2025 1:05 PM UTC

In a groundbreaking collaboration, Cibus and the John Innes Centre (JIC) are poised to bring significant advancements to the agricultural sector by potentially revolutionizing fertilizer usage. This partnership is exploring a novel genetic mutation that may substantially enhance nutrient uptake in crops, reducing reliance on artificial fertilizers and potentially reshaping t...

Shares

Cibus, Inc. Secures Strategic Investment to Propel Gene-Editing Innovations in Agriculture

Published Tue, Jan 21 2025 1:31 PM UTC

Cibus, Inc. Embarks on a New Chapter with Strategic Investment and Innovative Weed Management SolutionsJanuary 21, 2025, San Diego Cibus, Inc. (Nasdaq: CBUS) has set a transformative precedent in the realm of agricultural biotechnology. The company s recent financial maneuver, revealed in a press release, exemplifies how strategic investments are bridging the gap between gro...

Product Service News

Revolutionizing Rice Farming Cibus and Partners Set to Launch Gene-Edited Weed Management Solution

Published Sun, Dec 29 2024 9:09 PM UTC

In a groundbreaking development for U.S. agriculture, Cibus, in collaboration with Albaugh LLC and RTDC Company Limited, is making strides towards the commercialization of an innovative gene-edited herbicide tolerance solution specifically tailored for rice growers. This new technology promises not only to enhance productivity but also to promote sustainable agricultural pra...

Partnership

Cutting-Edge Collaboration Cibus and Biographica Leverage AI for Disease-Resistant Crops Amidst Financial Landscape

Published Tue, Nov 19 2024 12:30 PM UTC

In a significant move to advance agricultural biotechnology, Cibus Inc. (NASDAQ: CBUS) has announced a collaboration with Biographica to harness artificial intelligence (AI) for developing disease-resistant traits in canola and oilseed rape. This partnership aims to identify gene editing targets, marking a promising step forward in agricultural innovation. This article exami...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 28.07
Price to Sales (Expected) -
Price to Book 8.24
PEG (TTM) -

Financial Strength Current
Quick Ratio 1.41
Working Capital Ratio 1.62
Leverage Ratio (MRQ) 20.18
Total Debt to Equity 0.06
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -1.74 $
Revenues (TTM) 0.06 $
Cash Flow (TTM) -
Cash 0.27 $
Book Value 0.19 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 36,839
Net Income per Employee (TTM) -844,220
Receivable Turnover Ratio (TTM) 4.77
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.01

Profitability Ratios Current
Gross Margin (MRQ) 0 %
Operating Margin (MRQ) -1300.3 %
Net Margin (MRQ) -2227.87 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Cibus Inc's Segments
Reportable    269.11 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.